{
    "id": 30518,
    "fullName": "EGFR H773_V774delinsLM",
    "impact": "indel",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "EGFR H773_V774delinsLM results in a deletion of two amino acids in the protein kinase domain of the Egfr protein from aa 773 to aa 774, combined with the insertion of a leucine (L) and a methionine (M) at the same site (UniProt.org). H773_V774delinsLM has been identified in the scientific literature (PMID: 31175009), but has not been biochemically characterized and therefore, its effect on Egfr protein function is unknown (PubMed, Jan 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 15702,
                    "pubMedId": 31175009,
                    "title": "Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31175009"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "H773_V774delinsLM",
    "createDate": "07/16/2019",
    "updateDate": "01/30/2020",
    "referenceTranscriptCoordinates": {
        "id": 180903,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55181326_55181331delinsCTTATG",
        "cDna": "c.2317_2322delinsCTTATG",
        "protein": "p.H773_V774delinsLM",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17949,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case report, Tagrisso (osimertinib) in combination with Avastin (bevacizumab) resulted in clinical improvement in tumor lesions and metastasis sites in a patient with lung adenocarcinoma harboring EGFR H773_V774delinsLM (reported as H773L/V774M in cis), until disease progression after 12 months (PMID: 29858019).",
            "molecularProfile": {
                "id": 32712,
                "profileName": "EGFR H773_V774delinsLM"
            },
            "therapy": {
                "id": 4366,
                "therapyName": "Bevacizumab + Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14383,
                    "pubMedId": 29858019,
                    "title": "Case Report: Osimertinib achieved remarkable and sustained disease control in an advanced non-small-cell lung cancer harboring EGFR H773L/V774M mutation complex.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29858019"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17950,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case report, Iressa (gefitinib) treatment resulted in disease progression in a patient with lung adenocarcinoma harboring EGFR H773_V774delinsLM (reported as H773L/V774M in cis) 12 weeks after treatment (PMID: 29858019).",
            "molecularProfile": {
                "id": 32712,
                "profileName": "EGFR H773_V774delinsLM"
            },
            "therapy": {
                "id": 751,
                "therapyName": "Gefitinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 14383,
                    "pubMedId": 29858019,
                    "title": "Case Report: Osimertinib achieved remarkable and sustained disease control in an advanced non-small-cell lung cancer harboring EGFR H773L/V774M mutation complex.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29858019"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17951,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case report, Iressa (gefitinib) in combination with Avastin (bevacizumab) resulted in stable disease in a patient with lung adenocarcinoma harboring EGFR H773_V774delinsLM (reported as H773L/V774M in cis), until disease progression after 7 months (PMID: 29858019).",
            "molecularProfile": {
                "id": 32712,
                "profileName": "EGFR H773_V774delinsLM"
            },
            "therapy": {
                "id": 8651,
                "therapyName": "Bevacizumab + Gefitinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14383,
                    "pubMedId": 29858019,
                    "title": "Case Report: Osimertinib achieved remarkable and sustained disease control in an advanced non-small-cell lung cancer harboring EGFR H773L/V774M mutation complex.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29858019"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32712,
            "profileName": "EGFR H773_V774delinsLM",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 180903,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55181326_55181331delinsCTTATG",
            "cDna": "c.2317_2322delinsCTTATG",
            "protein": "p.H773_V774delinsLM",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}